Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $42.33 Average PT from Analysts

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has received a consensus rating of “Buy” from the six ratings firms that are currently covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have updated their coverage on the stock in […]

Leave a Reply

Your email address will not be published.

Previous post Astrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Rating of “Moderate Buy” from Analysts
Next post Red Rock Resorts Amends Credit Agreement, Reducing Interest Rates